-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RdFInIfF2/RAgFaChoFiv6Q2psqkU/JxtSti/r0GN7n2CBzwvYyaDjDSQeScazEZ 36fn6bnW26XsRJ541zd1gA== 0001181431-05-045637.txt : 20050809 0001181431-05-045637.hdr.sgml : 20050809 20050809202616 ACCESSION NUMBER: 0001181431-05-045637 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050608 FILED AS OF DATE: 20050809 DATE AS OF CHANGE: 20050809 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GORLIN STEVE CENTRAL INDEX KEY: 0001033742 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20837 FILM NUMBER: 051011578 BUSINESS ADDRESS: BUSINESS PHONE: 3012179858 MAIL ADDRESS: STREET 1: 150 GULF SHORE DRIVE STREET 2: UNIT 601 CITY: DESTIN STATE: FL ZIP: 32541 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIVATION, INC. CENTRAL INDEX KEY: 0001011835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133863260 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 501 SECOND STREET STREET 2: SUITE 211 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 BUSINESS PHONE: 415-543-3470 MAIL ADDRESS: STREET 1: 501 SECOND STREET STREET 2: SUITE 211 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 FORMER COMPANY: FORMER CONFORMED NAME: ORION ACQUISITION CORP II DATE OF NAME CHANGE: 19960408 4 1 rrd88645.xml X0202 4 2005-06-08 0 0001011835 MEDIVATION, INC. MDVN.OB 0001033742 GORLIN STEVE C/O MEDIVATION, INC. 501 SECOND STREET, SUITE 211 SAN FRANCISCO CA 94107 1 0 1 0 Common Stock 444487 I See Footnote Common Stock 2005-06-08 4 C 0 2212830 A 2212830 I See Footnote Common Stock Option 3.00 2005-08-05 4 A 0 50950 3.00 A 2005-08-05 2015-08-05 Common Stock 50950 50950 D Common Stock Warrant 1.55 2004-12-17 2013-10-10 Common Stock 129032 129032 I See Footnote Common Stock Warrant 1.55 2004-12-17 2014-04-01 Common Stock 32258 32258 I See Footnote Series B Convertible Preferred Stock 2005-06-08 4 C 0 110642 D 2004-12-17 Common Stock 2212830 0 I See Footnote Represents securities held by Dara BioSciences, Inc., of which the Reporting Person is the Chairman of the Board of Directors and a principal stockholder. Each share of the Series B Convertible Preferred Stock will be automatically converted into twenty (20) shares of Common Stock upon the occurrence of certain events. C. Patrick Machado, Attorney-In-Fact for Steve Gorlin 2005-08-09 -----END PRIVACY-ENHANCED MESSAGE-----